✦ LIBER ✦

Coordination of TP53 Abnormalities in Breast Cancer: Data from Analysis of TP53 Polymorphisms, Loss of Heterozygosity, Methylation, and Mutations

✍ Scribed by Denisov, Evgeny V.; Sukhanovskaya, Tatiana V.; Dultseva, Tatiana S.; Malinovskaya, Elena A.; Litviakov, Nicolay V.; Slonimskaya, Elena M.; Choinzonov, Evgeny L.; Cherdyntseva, Nadezhda V.

Book ID: 121260417
Publisher: Mary Ann Liebert
Year: 2011
Tongue: English
Weight: 253 KB
Volume: 15
Category: Article
ISSN: 1945-0265
DOI: 10.1089/gtmb.2011.0038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Studies of TP53 haplotypes in relation t

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients

✍ A Langerød, TI Andersen, I Bukholm, A-L Børresen Dale 📂 Article 📅 2000 🏛 BioMed Central 🌐 English ⚖ 298 KB

Mutation and methylation analysis of TP5

Mutation and methylation analysis of TP53 in adrenal carcinogenesis

✍ S. Sidhu; E. Martin; C. Gicquel; J. Melki; S.J. Clark; P. Campbell; C.J. Magarey 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Abnormal expression or mutation of TP53

Abnormal expression or mutation of TP53 and HPV in vulvar cancer

✍ H.Y.S Ngan; A.N.Y Cheung; S.S Liu; P.S.F Yip; S.W Tsao 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 66 KB

High frequency of complex TP53 mutations

High frequency of complex TP53 mutations in CNS metastases from breast cancer

✍ Lo Nigro, C; Vivenza, D; Monteverde, M; Lattanzio, L; Gojis, O; Garrone, O; Comi 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 631 KB

Loss of heterozygosity at the TP53 gene:

Loss of heterozygosity at the TP53 gene: Independent occurrence from genetic instability events in node-negative breast cancer

✍ Sarab Lizard-Nacol; Jean-Marc Riedinger; Gérard Lizard; Anne-Lise Glasser; Nolwe 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 2 views

TP53 abnormalities have been reported as an early event in the process of cellular transformation of human breast cancers, and involved in mammary-tumor evolution, from in situ to invasive disease. In this study, node-negative (N-) tumors were examined for TP53 allelic loss in relation to different

Loss of heterozygosity of BRCA1, TP53 an

Loss of heterozygosity of BRCA1, TP53 and TCRD markers analysed in sporadic endometrial cancer

✍ D Niederacher; H.-X An; S Camrath; S.I Dominik; U.J Göhring; A Oertel; M Grass; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 191 KB